Incyte Lays off 400 and Shutters Facilities As it Reverts to Original Database Model | GenomeWeb

In a time when most database vendors in the industry are moving away from their data-provider models and adopting a larger discovery role, analysts noted last week that Incyte Genomics’ recent refocus on its information business is most likely an interim strategy until the company firms up its plans to tackle discovery.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.